Candriam SCA’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-502,177
| Closed | -$3.06M | – | 837 |
|
|
2020
Q2 | $3.06M | Buy |
502,177
+502,171
| +8,369,517% | +$3.06M | 0.03% | 418 |
|
|
2020
Q1 | $0 | Buy |
+6
| New | – | ﹤0.01% | 797 |
|
|
2018
Q3 | – | Sell |
-80,000
| Closed | -$1.27M | – | 856 |
|
|
2018
Q2 | $1.27M | Hold |
80,000
| – | – | 0.02% | 564 |
|
|
2018
Q1 | $1.37M | Hold |
80,000
| – | – | 0.02% | 539 |
|
|
2017
Q4 | $1.75M | Buy |
80,000
+30,000
| +60% | +$658K | 0.03% | 481 |
|
|
2017
Q3 | $2.05M | Sell |
50,000
-9,000
| -15% | -$368K | 0.04% | 449 |
|
|
2017
Q2 | $1.78M | Buy |
59,000
+27,000
| +84% | +$813K | 0.03% | 486 |
|
|
2017
Q1 | $1.16M | Hold |
32,000
| – | – | 0.02% | 541 |
|
|
2016
Q4 | $1.6M | Buy |
32,000
+8,000
| +33% | +$401K | 0.04% | 410 |
|
|
2016
Q3 | $1.26M | Sell |
24,000
-3,000
| -11% | -$158K | 0.03% | 449 |
|
|
2016
Q2 | $1.12M | Sell |
27,000
-9,000
| -25% | -$372K | 0.03% | 414 |
|
|
2016
Q1 | $1.46M | Sell |
36,000
-75,300
| -68% | -$3.04M | 0.04% | 369 |
|
|
2015
Q4 | $4.62M | Buy |
111,300
+14,000
| +14% | +$581K | 0.12% | 188 |
|
|
2015
Q3 | $1.5M | Buy |
+97,300
| New | +$1.5M | 0.04% | 382 |
|